Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: A randomized, double-blind trial showing the importance of metronidazole resistance

American Journal of Gastroenterology

Volumn 93, Issue 1, 1998, Pages 5-10

  Veldhuyzen Van Zanten, S ^a   Hunt, R H ^a   Cockeram, A ^a   Schep, G ^a   Malatjalian, D ^a   Sidorov, J ^a   Matisko, A ^a   Jewell, D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG RESISTANCE; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH BIOPSY; TREATMENT OUTCOME; VAGINA CANDIDIASIS;

ADOLESCENT; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BIOPSY; CHRONIC DISEASE; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ENDOSCOPY; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PLACEBOS; STOMACH; TIME FACTORS;

EID: 0002862031     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(97)00023-3     Document Type: Article

References (39)

1. Veldhuyzen van Zanten SJO, Sherman PM. Helicobacter pylori infection as the cause of gastritis, duodenal ulcer, gastric cancer and non-ulcer dyspepsia: A systematic overview. Can Med Assoc J. 150:1994;177-185.
2. Chiba N, Rao B, Rademaker J. Meta-analysis of the efficacy of antibiotic therapy eradicating Helicobacter pylori. Am J Gastroenterol. 87:1992;1716-1727.
3. Biasco G, Miglioli M, Barbara L. Omeprazole, Helicobacter pylori, gastritis and duodenal ulcer. Lancet. 2:1989;1403.
4. Goh KL, Peh C, Parasakthi N. Omeprazole 40 mg om combined with amoxicillin alone or with amoxicillin and metronidazole in the eradication of H. pylori. Am J Gastroenterol. 89:1994;1789-1792.
5. Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol. 29:1994;16-23.
6. Bazzoli F, Zagari RM, Fossi P. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroeneterol Hepatol. 6:1994;773-777.
7. Lind T, Veldhuyzen van Zanten SJO, Unge P. Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study. Helicobacter. 1:1996;138-144.
8. Manning AP, Thomson WG, Heaton KW. Towards a positive diagnosis of inflammatory bowel syndrome. BMJ. ii:1978;653-654.
9. Veldhuyzen van Zanten SJO, Tytgat KMAJ, Pollak PT. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis. J Clin Epidemiol. 46:1993;273-279.
10. Goodwin S, Blincow ED, Warren JR. Evaluation of culture techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol. 38:1985;1127-1131.
11. Misiewicz JJ, Tytgat GNJ, Goodwin CS. The Sydney System: A new classification of gastritis. World Congress of Gastroenterology 1990, Sydney, Australia. 1990;1-10. Working Party Reports.
12. Price AB. The Sydney System: Histological division. J Gastroenterol Hepatol. 6:1991;209-222.
13. Glupczynski Y, Labbe M, Hansen W. Evaluation of the E-test for qualitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol. 29:1991;2072-2075.
14. Cederbrant G, Kahlmeter G, Ljungh A. The E-test for antimicrobial susceptibility testing of Helicobacter pylori. J Antimicrob Chemother. 31:1993;65-71.
15. Colton TH. Statistics in medicine. Boston: Little, Brown. 1974;169.
16. Patchett S, Beattie S, Leen E. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ. 303:1991;1238-1240.
17. Burette A, Glupczynski Y, de Prez C. Evaluation of various multi-drug eradication regimens for Helicobacter pylori. Eur J Gastroenterol Hepatol. 4:1992;817-823.
18. Loo VG, Sherman PM, Matlow AG. Helicobacter pylori infection in a pediatric population: In vitro susceptibilities to omeprazole and eight antimicrobial agents. Scand J Gastroenterol. 36:1992;1133-1135.
19. Hui WM, Lam SK, Ho J. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci. 36:1991;577-582.
20. Weil J, Bell GD, Powell K. Omeprazole and Helicobacter pylori: Temporary suppression rather than true eradication. Aliment Pharmacol Ther. 5:1991;309-313.
21. Kuipers EJ, Klinkenberg-Knol EC, Festen HPM. Long-term omeprazole therapy does not affect the Helicobacter pylori status in most patients. Scand J Gastroenterol. 28:1993;978-980.
22. Bayerdorffer E, Mannes GA, Sommer A. High dose treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol. 4:1992;697-702.
23. Bayerdorffer E, Miellke S, Mannes GA. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology. 108:1995;1412-1422.
24. Logan RP, Gummett PA, Hegarty BT. Clarithromycin and omeprazole for Helicobacter pylori. Lancet. 340:1992;239.
25. Penston JG. Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther. 8:1994;369-389.
26. Bell GD, Powell KU, Burridge SM. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 9:1995;41-46.
27. Powell KU, Bell GD, Rowden A. Helicobacter pylori eradication therapy: A comparison between either omeprazole or ranitidine in combination with amoxicillin plus metronidazole. Gut. 35:1994;S16. (suppl 5).
28. Bell GD, Powell KU, Burridge SM. Helicobacter pylori eradication: Efficacy and side effect profile of a combination of omeprazole, amoxicillin and metronidazole compared with four alternative regimens. Q J Med. 86:1993;743-750.
29. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. Results of a multicenter European survey in 1991 of metronidazole resistance in Helicobacter pylori Eur J Microbiol Infect Dis. 11:1992;777-781.
30. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol. 88:1993;505-509.
31. Graham DY, Lew GM, Klein PD, et al. Factors affecting the eradication of Helicobacter pylori infection with triple therapy. Gastroenterology. 102:1992;493-496.
32. Dixon MF. Spectrum and implications of inflammation with Helicobacter pylori. Hunt RH, Tytgat GNJ. Helicobacter pylori. 1994;353-361 Kluwer Academic Publishers, London. Amelia Island Meeting, 1993.
33. Elta GH, Appelman HD, Beheler EM. A study of the correlation between endoscopic and histologic diagnosis in gastroduodenitis. Am J Gastroenterol. 82:1987;749-753.
34. Taor RE, Fox B, Ware J. Gastritis - gastroscopic and microscopic. Endoscopy. 7:1975;209-215.
35. Sauerbruch T, Schreiber MA, Schussler P. Endoscopy in the diagnosis of gastritis. Diagnostic value of endoscopic criteria in relation to histologic diagnosis. Endoscopy. 16:1984;101-104.
36. Veldhuyzen van Zanten SJO. A systematic overview (meta-analysis) of outcome measures in patients with Helicobacter pylori gastritis trials and functional dyspepsia. Scand J Gastroenterol. 28:1993;40-43. (suppl 199).
37. Talley NJ. A critique of therapeutic trials in Helicobacter pylori positive functional dyspepsia. Gastroenterology. 106:1994;1174-1183.
38. Veldhuyzen van Zanten SJ, Malatjalian D, Tanton R. The effect of eradication of Helicobacter pylori on symptoms of non-ulcer dyspepsia. A randomized double-blind placebo controlled trial. Gastroenterology. 108:1995;A250. (abstract).
39. O'Morain C, Gilvarry J. Eradication of H. pylori in patients with non-ulcer dyspepsia. Scand J Gastroenterol. 28:1993;30-33. (suppl 196).